biosint nucleotidos
DESCRIPTION
biosíntesis de nucleótidosTRANSCRIPT
11/7/14
1
MBIO 2100 ������
Lehninger Principles of Biochemistry, 4th ed. ���
CHAPTER 22 (pp. 862 - 876) (Chapters 22, pp. 848 - 865, 3rd ed.)
Biosynthesis and Degradation of
Nucleotides
Text and figures from Lehninger 3rd ed. or 4th ed.
The pools (reservas) of nucleotides in cells are < 1% of the quantities required for DNA synthesis. How does the cell get the nucleotides it needs? • Synthesis pathways • Salvage (reciclaje) pathways
Synthetic pathways • Identical in nearly all organisms • Free bases are NOT pathway intermediates • Precursors - Source of N: Gln, NH3 PRPP (from ribose-5-phosphate) Gly, Asp, Formate (purines) Asp (pyrimidines) HCO3
-
Salvage pathways • recycle free bases and nucleosides from nucleic
acid degradation.
Origin ring atoms determined by Buchanon (1950s) using 14C- and 15N-labeled precursors in birds.
Purine Nucleotide Biosynthesis
Purine biosynthesis. Steps 1 - 2 Precursors PRPP + Gln The purine ring is built on top of the ribose-5-phosphate.
Purine Nucleotide Biosynthesis
11/7/14
2
Purine biosynthesis. Steps 3 - 4
Folate is a source of carbon
Purine Nucleotide Biosynthesis
Purine biosynthesis. Steps 5 - 6
Purine Nucleotide Biosynthesis
Purine biosynthesis. Steps 7 - 8
Purine Nucleotide Biosynthesis
Purine biosynthesis. Steps 9 - 11 Up to the formation of inosinate, IMP, 5 ATPs are consumed.
Purine Nucleotide Biosynthesis
Formation of AMP and GMP from IMP. One additional GTP/ATP consumed per product.
Purine Nucleotide Biosynthesis
Regulation of purine biosynthesis.!!1(a) The end product ADP inhibit the synthesis of the precursor PRPP.!!1(b) The first unique step in the pathway is feedback-inhibited by the end products IMP, GMP, AMP.!
Purine Nucleotide Biosynthesis
11/7/14
3
Regulation of purine biosynthesis.!!2 (a) An excess of GMP inhibits the formation of GMP from IMP.!!2 (b ) An excess of AMP inhibits the formation of AMP from IMP. !
Purine Nucleotide Biosynthesis
Regulation of purine biosynthesis.!!3. GTP is required for the synthesis of AMP from IMP. ATP is required for the synthesis of GMP from IMP.!!This level of control balances the synthesis of AMP and GMP.
Purine Nucleotide Biosynthesis
Pyrimidine biosynthesis. Precursors: HCO3
-, 2ATP, glutamine, PRPP The pyrimidine ring is built first, and then attached to PRPP. Steps 1 - 5
HCO3- + 2ATP + glutamine glu + P i
Pyrimidine Nucleotide Biosynthesis
carbamoyl phosphate synthetase
Pyrimidine biosynthesis. 6 steps to form UMP. Additional steps required to form CTP.
Pyrimidine Nucleotide Biosynthesis
Pyrimidine biosynthesis in animals and bacteria animals: • 2 separate enzymes produce carbamoyl phosphate. Carbamoyl
phosphate synthetase II (CPSII) is the enzyme in pyrimidine biosynthesis. What other pathway uses a CPS?
• Step 1 is regulated (CPSII)
• Steps 1 - 3 are catalyzed by a large, multifunctional enzyme called CAD. bacteria: • Only one enzyme produces carbamoyl phosphate for both
pathways.
• Step 2 is regulated (aspartate transcarbamoylase)
• Steps 1 - 3 are catalyzed by monofunctional enzymes.
Pyrimidine Nucleotide Biosynthesis
Urea cycle associated carbamoyl synthetase I (CPS I) in mammals. Bacteria have only one CPS that is used for both urea cycle and pyrimidine biosynthesis.
Pyrimidine Nucleotide Biosynthesis
11/7/14
4
bacteria animals
carbamoyl phosphate
CPS (general)
ATCase urea cycle carbamoyl phosphate
WHERE TO REGULATE PYRIMIDINE BIOSYNTHESIS???
UMP
CPS II (dedicated)
ATCase
UMP
Pyrimidine Nucleotide Biosynthesis
In bacteria, the pathway is regulated at step 2, by allosteric regulation of aspartate transcarbamoylase
Sigmoidal saturation curves are typical of allosterically regulated enzymes. K0.5 is the [S] at 1/2 Vmax.
Pyrimidine Nucleotide Biosynthesis
Nucleoside monophosphates are converted to nucleoside triphosphates.
glycolysis or oxid. phosphoryl.
1 adenylate kinase ATP + AMP <––> 2ADP –> –> –> –> –> ATP
2. nucleoside monophosphate kinases ATP + NMP <––> ADP + NDP
3. nucleoside diphosphate kinase NTP + NDP <––> NDP + NTP
Kinases
Deoxyribonucleotides (for DNA) are derived from the corresponding ribonucleotides.
Reaction catalyzed by ribonucleotide reductase (RR).
Formation of deoxyribonucleotides
Source of electrons: glutaredoxin (GSH) and thioredoxin (FADH2). GSH and FADH2 are reduced by NADPH.
Note: nucleotide diphosphates are the substrates for the reaction.
Formation of deoxyribonucleotides
Ribonucleotide reductase activity is regulated. • Regulation of enzyme’s activity (primary regulation site) • Regulation of enzyme’s substrate specificity (specificity site)
Formation of deoxyribonucleotides
11/7/14
5
Formation of Thymidylate. DNA contains thymine rather than uracil.
The precursor of dTMP is dUTP.
In the cell [dUTP] is low to prevent incorporation into DNA.
Thymidylate synthase
Thymidylate Synthase. The methyl group of dTMP originates from tetrahydrofolate. Tetrahydrofolate is an enzyme cofactor involved in transfer of 1-carbon units.
Thymidylate synthase
Purine Degradation. Purines are degraded to xanthine. In humans, xanthine oxidase converts xanthine into uric acid, which is excreted. (primates, reptiles, aves, insectos)
Degradation pathways
Purine Degradation. Genetic deficiencies in adenosine deaminase result in severe immunodeficiency. Patients must live in a sterile environment.
Degradation pathways
Pyrimidine Degradation. The pathways generally lead to formation of NH4+.
Degradation pathways
Salvage (Recycling) Pathways Free purines and pyrimidines from catabolism of nucleotides are salvaged (recycled). Adenosine phophoribosyl transferase Adenine + PRPP –> AMP + PPi Hypoxanthine-guanine phophoribosyl transferase
(HGPRTase) Hypoxanthine/Guanine + PRPP –> IMP/GMP + PPi
Genetic deficiency causes Lesch-Nyhan syndrome (automutilación y retardo mental).
Salvage pathways
11/7/14
6
Gout (gota) Elevated blood [uric acid], possibly due to deficiencies in purine metabolism. Excess uric acid is deposited in the joints, kidney. Treatment: xanthine oxidase Inhibitor, allopurinol
Drug targets in nucleotide metabolism
Allopurinol inhibits xanthine oxidase.
Drug targets in nucleotide metabolism
“Pyrimidine biosynthesis is invariably up-regulated in tumors and neoplastic cells.”
Evans and Guy J Biol Chem. (2004) PMID: 15096496
Cancer cells grow more rapidly than normal cells, and have a greater requirement for nucleotide precursors of DNA and RNA.
Cancer Chemotherapy
Drug targets in nucleotide metabolism
Cancer Chemotherapy Chemotherapeutic agents that inhibit enzymes of nucleotide synthesis. Example: Glutamine analogs.
Drug targets in nucleotide metabolism
Inhibition of dTMP production by FdUMP, methotrexate, and aminopterin.
Drug targets in nucleotide metabolism